Represents first step towards a potential clinical treatment of locally advanced pancreatic cancer LYON, France, January 13, 2022 -- EDAP TMS...
- First clinical combination study of BBP-398 and LUMAKRAS set to evaluate safety and preliminary efficacy in solid tumors with...
With the addition of psilocybin and MDMA to Health Canada’s Special Access Program, Mydecine looks to offer a package of...
SOUTH ORANGE, NJ, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology...
Headset data confirms Auxly almost doubled overall market share, ending the year as the #5 LP in Canada and continues...
TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a...
CINCINNATI, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based...
LONDON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell...
Congenica Expands its Clinical Consulting Services Cambridge, United Kingdom – 13 January 2022 - Congenica, the digital health company enabling...
Helsinn Launches Fully Integrated Targeted Therapy (FITT) Strategy and Announces Leadership and Structural Changes Strategy focuses on developing and commercializing...
– Lead candidate ONL1204 Ophthalmic Solution has advanced into chronic indications of open-angle glaucoma (OAG) and geographic atrophy (GA) associated...
Positive interim biomarker data supports specific immune signature induced by IMCY-0098 and effect on potentially pathogenic T cells Enrollment on...
Company filed two provisional patent applications for new enteric granule formulation of adrulipase and for related nutritional indications in new...
Conference call and live audio webcast scheduled for today at 8:30 a.m. ESTTransformative acquisition significantly expands Salarius’ oncology pipeline into...
Industry Veteran Will Lead Company’s Commercial Growth Strategy in Americas RegionMENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio...
Franchise includes AMZEEQ® for the treatment of acne and ZILXI® for the treatment of rosacea, and a development-stage dermatology program...
-- Phase 2/3 GRANITE-CRC-1L trial has registrational intent -- -- Updated data from Phase 1/2 trial in end-stage metastatic MSS-CRC...
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies...
Transaction includes cash payments of $25 million and potential milestones of up to $450 million Sale aligns with VYNE’s strategic...
CARLSBAD, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on...
